Hydromorphone

American Journal of Nursing

Volumn 101, Issue 2, 2001, Pages 22-23

  Pasero, Chris ^a   McCaffery, Margo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROMORPHONE; MORPHINE; NARCOTIC ANALGESIC AGENT; PETHIDINE;

ARTICLE; CHRONIC DISEASE; COMPARATIVE STUDY; HUMAN; NEOPLASM; PAIN; PATHOPHYSIOLOGY;

ANALGESICS, OPIOID; CHRONIC DISEASE; HUMANS; HYDROMORPHONE; MEPERIDINE; MORPHINE; NEOPLASMS; PAIN;

EID: 0035257318     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000446-200102000-00027     Document Type: Article

References (8)

1. Agency for Health Care Policy and Research. Acute pain management: operative or medical procedures and trauma. Rockville (MD): Department of Health and Human Services; 1992. AHCPR Pub. No. 92-0032. (Clinical practice guideline).
2. Coda B, et al. Hydromorphone analgesia after intravenous bolus administration. Pain 1997;71(1):41-8.
3. Rapp SE, et al. A multidimensional comparison of morphine and hydromorphone patient-controlled analgesia. Anesth Analg 1996;82(5):1043-8.
4. Foley KM. Misconceptions and controversies regarding the use of opioids in cancer pain. Anticancer Drugs 1995;6(Suppl 3):4-13.
5. Dunbar PJ, et al. Clinical analgesic equivalence for morphine and hydromorphone with prolonged PCA. Pain 1996;68(2-3):265-70.
6. Levy MH. Pharmacologic treatment of cancer pain. N Engl J Med 1996;335(15):1124-32.
7. Lawlor P, et al. Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study. Pain 1997;72(1-2):79-85.
8. Pasero C, et al. Opioid analgesics. In: McCaffery M, Pasero C. Pain: clinical manual. 2nd ed. St. Louis: Mosby; 1999. p. 161-299.